Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
Clinical trial NCT04503252 · COMPLETED
Trial details
- NCT number
- NCT04503252
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-14
- Primary completion
- 2022-03-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.